News & Highlights
- Patient Care
- Research
- Cancer
Study offers new data on hormone therapy timing strategies when prostate cancer relapse is detected by rising PSA levels alone.
- Urologic Subspecialties
Professor Jack McAninch has logged thousands of miles in the corridors of San Francisco General Hospital (SFGH) since he became urology chief there in 1977.
- Research
- Urologic Subspecialties
Post-traumatic stress disorder (PTSD) is categorized as a mental health problem, but it can also produce a range of physical symptoms.
- Patient Care
- Research
- Education
- Cancer
The American Association of Genitourinary Surgeons awarded its 2014 Barringer Medal to Peter R. Carroll, MD, MPH, chair of the UCSF Department of Urology ...
- Patient Care
- Urologic Subspecialties
Clay del Rosario, a nurse at the Urology Procedure Center, is a recipient of a Daisy Award for 
- Patient Care
- Research
- Cancer
Dr. Maurice Garcia, MD, MAS, Assistant Professor of Urology, UCSF designed and developed an implantable fiducial marker for the bladder that allows Radiation Oncologists to visualize and target the tumor site with high-dosages of radiotherapy, and is spearheading ongoing research to develop their role in clinical treatment.
- Patient Care
- Research
- Urologic Subspecialties
Ben Breyer, MD, MAS is once again in the news for his compelling research culled from large data sources. Breyer uses data collected from the National Electronic Injury Surveillance System to search genital injuries: this time, as it relates to bike riding...
Pages
Filter By Topic
Filter by Date
Media Contact
Elizabeth Fernandez
UCSF Department of Urology
San Francisco, CA 94143
[email protected]
415/514-1592
UCSF researchers make an important scientific breakthrough that connects two fundamental cellular processes, protein synthesis and metabolism, important for fueling cancer cell growth. Remarkably, the targeted inhibition of this specific connection caused cancer cells but not normal cells to die, therefore identifying an attractive new approach to cancer therapy.